TechnologyNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1023459SLP stock profile & AI dashboard →

13F Pro Quality Score

37.4/100

Rank #2,057 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

71.9/100

Profitability

8.6/100

Balance Sheet

3.9/100

Earnings Quality

30.0/100

Free Cash Flow

84.7/100

Institutional Flow

62.8/100

Revenue Scale

15.8/100

Dilution Risk

19.6/100

SLP Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Simulations Plus, Inc. (SLP), a Technology sector company. 13F Pro's AI-powered ranking engine scores SLP at 37.4/100 on a 32-signal composite quality model, placing it at rank #2,057 of 2,879 stocks — the bottom half of the AI-ranked universe. SLP scores in the top quartile across free cash flow (84.7). Areas of concern include balance sheet strength (3.9) and profitability (8.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 19.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Simulations Plus, Inc. reports quarterly revenue of $24.3M, net income of $4.5M, free cash flow of $6.4M. Top institutional holders of SLP by reported 13-F value include First Light Asset Management,, BlackRock,, MORGAN STANLEY, based on the most recent SEC filings. SLP trades on the Nasdaq exchange and files with the SEC under CIK 1023459. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SLP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Simulations Plus, Inc. directly from SEC EDGAR. Simulations Plus, Inc.'s 13F Pro composite quality score has ranged between 8 and 67 since 2021, currently 37.4 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about Simulations Plus, Inc.

Quirks, history, and lore behind SLP — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. software and services company · small-cap · listed on Nasdaq · headquartered in California.
  • 2
    The Numbers
    Annual revenue in the range of $50–60 million — tiny by tech standards, yet it commands a premium valuation thanks to sticky, specialized customers.
  • 3
    The History
    Founded in the 1990s, it grew out of academic research into mathematical modeling and carved out a niche that the pharma industry quietly depends on.
  • 4
    The Secret
    Its software doesn't make drugs — it simulates how drugs behave inside the human body, helping researchers predict outcomes before a single patient is dosed.
  • 5
    The Lore
    Its flagship product, used across pharmaceutical and biotech R&D, models ADMET properties — how a drug is absorbed, distributed, metabolized, excreted, and whether it's toxic.
  • 6
    The Giveaway
    When a drug company wants to know if a molecule will survive the human body, they fire up GastroPlus — the gold-standard physiologically based pharmacokinetic simulation tool built by this niche software firm.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$24.3M

Net Income

Q2 2026

$4.5M

Free Cash Flow

Q2 2026

$6.4M

Get alerted when SLP's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Simulations Plus, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put SLP on your watchlist

Track score changes the day Simulations Plus, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is SLP a good stock to buy?

13F Pro's AI-powered analysis of Simulations Plus, Inc. (SLP) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SLP are available on the SLP stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SLP?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SLP. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Simulations Plus, Inc.'s investment landscape.